Literature DB >> 21338441

Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation.

Takashi Yokoyama1, Takuro Nakamura.   

Abstract

The tribbles family of genes encodes pseudokinase proteins that are highly conserved in evolution. Instead of direct phosphorylation of target proteins, tribbles act as adaptors in signaling pathways for important cellular processes. These include mitogen-activated protein kinase kinase (MAPKK), CCAAT/enhancer-binding protein (C/EBP), activating transcription factor 4 (ATF4) and C/EBP-homologous protein (CHOP). Trib1 and Trib2 have been identified as myeloid oncogenes, and both may be involved in human leukemia. Tribbles proteins are also involved in a series of non-neoplastic disorders including metabolic and neurological diseases. The RAS/mitogen-activated protein kinase (MAPK) pathway molecules (in particular MAPK/ERK kinase 1 (MEK1) and C/EBP transcription factors) include tribbles-binding proteins that are involved in leukemogenesis, and the role of Trib1 as a linker between MAPK signaling and C/EBP degradation is proposed. Although the molecular function of tribbles is still under investigation, the research on tribbles in cellular processes, homeostasis of organisms and human diseases will provide valuable information for therapy of cancer as well as non-neoplastic disorders.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338441     DOI: 10.1111/j.1349-7006.2011.01914.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  63 in total

1.  Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling.

Authors:  Shu-Chen Wei; Ian M Rosenberg; Zhifang Cao; Alan S Huett; Ramnik J Xavier; Daniel K Podolsky
Journal:  Inflamm Bowel Dis       Date:  2012-01-23       Impact factor: 5.325

2.  Trb3 regulates LR axis formation in zebrafish embryos.

Authors:  Mrudhula Anuppalle; Sateesh Maddirevula; Tae-Lin Huh; Myungchull Rhee
Journal:  Mol Cells       Date:  2013-11-27       Impact factor: 5.034

3.  Identification of tribbles-1 as a novel binding partner of Foxp3 in regulatory T cells.

Authors:  Emilie Dugast; Endre Kiss-Toth; Louise Docherty; Richard Danger; Mélanie Chesneau; Virginie Pichard; Jean-Paul Judor; Ségolène Pettré; Sophie Conchon; Jean-Paul Soulillou; Sophie Brouard; Joanna Ashton-Chess
Journal:  J Biol Chem       Date:  2013-02-15       Impact factor: 5.157

4.  Sin3A-associated protein, 18 kDa, a novel binding partner of TRIB1, regulates MTTP expression.

Authors:  Saho Makishima; Supichaya Boonvisut; Yuumi Ishizuka; Kazuhisa Watanabe; Kazuhiro Nakayama; Sadahiko Iwamoto
Journal:  J Lipid Res       Date:  2015-04-28       Impact factor: 5.922

Review 5.  Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.

Authors:  Andréia Vasconcelos-Dos-Santos; Rafaela Muniz de Queiroz; Bruno da Costa Rodrigues; Adriane R Todeschini; Wagner B Dias
Journal:  J Bioenerg Biomembr       Date:  2018-01-11       Impact factor: 2.945

6.  MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals.

Authors:  Qing Lv; Jin-Xia Hu; You-Jie Li; Ning Xie; Dan Dan Song; Wei Zhao; Yun-Fei Yan; Bao-Sheng Li; Ping-Yu Wang; Shu-Yang Xie
Journal:  Cancer Biol Ther       Date:  2017-01-20       Impact factor: 4.742

7.  Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.

Authors:  Takaomi Sanda; Lee N Lawton; M Inmaculada Barrasa; Zi Peng Fan; Holger Kohlhammer; Alejandro Gutierrez; Wenxue Ma; Jessica Tatarek; Yebin Ahn; Michelle A Kelliher; Catriona H M Jamieson; Louis M Staudt; Richard A Young; A Thomas Look
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

8.  Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.

Authors:  Seiko Yoshino; Takashi Yokoyama; Yoshitaka Sunami; Tomoko Takahara; Aya Nakamura; Yukari Yamazaki; Shuichi Tsutsumi; Hiroyuki Aburatani; Takuro Nakamura
Journal:  Blood       Date:  2021-01-07       Impact factor: 22.113

9.  High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.

Authors:  Julia Izrailit; Hal K Berman; Alessandro Datti; Jeffrey L Wrana; Michael Reedijk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

10.  ATF4 and HIF-1α in bone: an intriguing relationship.

Authors:  Ernestina Schipani; Laura Mangiavini; Christophe Merceron
Journal:  J Bone Miner Res       Date:  2013-09       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.